Fernanda Almeida Andrade

Dr. Fernanda Almeida Andrade


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2023 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
SFSilas Ramos Furquim
Silas Ramos Furquim
BLBianca Linnenkamp
Bianca Linnenkamp
NONatalia Quintella Sangiorgi Olivetti
Natalia Quintella Sangiorgi Olivetti
FGFernando Rabioglio Giugni
Fernando Rabioglio Giugni
LLLayara Fernanda Vicente Pereira Lipari
Layara Fernanda Vicente Pereira Lipari
JKJosé Eduardo Krieger
José Eduardo Krieger
Resumo Os testes genéticos para cardiomiopatia dilatada (CMD) apresentam uma positividade de até 40%, mas há uma grande heterogeneidade genética e outros desafios decorrentes de expressividade variável e penetrância incompleta. O heredograma é fundamental para diferenciar os casos de CMD esporádica e familiar, por meio da avaliação do histórico familiar. A CMD familiar apresenta um rendimento maior nos testes genéticos, mas a CMD esporádica não exclui a possibilidade de causa genética. Alguns genes têm fenótipos específicos, sendo o gene da [...] Resumo Os testes genéticos para cardiomiopatia dilatada (CMD) apresentam uma positividade de até 40%, mas há uma grande heterogeneidade genética e outros desafios decorrentes de expressividade variável e penetrância incompleta. O heredograma é fundamental para diferenciar os casos de CMD esporádica e familiar, por meio da avaliação do histórico familiar. A CMD familiar apresenta um rendimento maior nos testes genéticos, mas a CMD esporádica não exclui a possibilidade de causa genética. Alguns genes têm fenótipos específicos, sendo o gene da

31 December 2023 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
FAFernanda Almeida Andrade
Fernanda Almeida Andrade
LMLuana Monferdini
Luana Monferdini
JVJefferson Luís Vieira
Jefferson Luís Vieira
Heart failure (HF) is a progressive condition, characterized by variable periods of symptomatic stability frequently interrupted by episodes of A worsening condition. These moments of clinical deterioration have been recognized as a distinct phase in the course of HF and indicate a considerably worse prognosis. Preventing readmissions of patients with HF is a growing priority for medical providers, researchers, and healthcare managers. Although evidence-based therapies for treating patients with HF have increased, consistent implementation of these therapies and the [...] Abstract Heart failure (HF) is a progressive condition, characterized by variable periods of symptomatic stability frequently interrupted by episodes of A worsening condition. These moments of clinical deterioration have been recognized as a distinct phase in the course of HF and indicate a considerably worse prognosis. Preventing readmissions of patients with HF is a growing priority for medical providers, researchers, and healthcare managers. Although evidence-based therapies for treating patients with HF have increased, consistent implementation of these therapies and the

1 May 2025 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
NONatalia Quintella Sangiorgi Olivetti
Natalia Quintella Sangiorgi Olivetti
MPMárya Pagotti
Márya Pagotti
BSBruno Moreira Santos
Bruno Moreira Santos
MMMarjorie Mizuta
Marjorie Mizuta
BLBianca Linnenkamp
Bianca Linnenkamp
JKJose Krieger
Jose Krieger
Filamin C (FLNC) plays a critical role in maintaining the structural integrity of muscle cells, particularly within the cardiac sarcomere. Pathogenic variants in the FLNC gene are increasingly recognized as significant contributors to a diverse range of cardiomyopathies, including dilated (DCM), hypertrophic (HCM), arrhythmogenic (ACM), and restrictive cardiomyopathy (RCM). This review explores the genotype-phenotype correlations in FLNC-related cardiomyopathies, emphasizing how the type and location of genetic variants influence the clinical presentation. Truncating variants are primarily associated with DCM and [...] Abstract Filamin C (FLNC) plays a critical role in maintaining the structural integrity of muscle cells, particularly within the cardiac sarcomere. Pathogenic variants in the FLNC gene are increasingly recognized as significant contributors to a diverse range of cardiomyopathies, including dilated (DCM), hypertrophic (HCM), arrhythmogenic (ACM), and restrictive cardiomyopathy (RCM). This review explores the genotype-phenotype correlations in FLNC-related cardiomyopathies, emphasizing how the type and location of genetic variants influence the clinical presentation. Truncating variants are primarily associated with DCM and

1 January 2025 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
FAFernanda Almeida Andrade
Fernanda Almeida Andrade
Preditores de mortalidade: O papel da avaliação clínica pormenorizada A relevância de uma boa consulta médica deve ser rememorada quando trata-se da avaliação desses casos, através de uma anamnese conseguimos extrair possíveis preditores de mortalidade, como por exemplo: idade, FEVE, valor de BNP e/ou NT-proBNP, doença arterial coronariana (DAC), diabetes mellitus, insuficiência renal crônica, ritmo basal, hospitalização por IC e NYHA >2. A partir do descrito, o trabalho de Başkurt et al. traz valores como BNP > 508,5 pg/mL (ROC:

18 October 2024 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
SFSilas Ramos Furquim
Silas Ramos Furquim
PSPaula de Mendonça Senra
Paula de Mendonça Senra
BLBianca Linnenkamp
Bianca Linnenkamp
KVKelvin Henrique Vilalva
Kelvin Henrique Vilalva
MMMarjorie Hayashida Mizuta
Marjorie Hayashida Mizuta
JKJose Krieger
Jose Krieger
Titin, encoded by the TTN gene, is the largest human protein, essential for maintaining muscle cell stability and regulating myocardial contraction. TTN truncating variants (TTNtv) have emerged as the most common genetic cause of dilated cardiomyopathy (DCM), accounting for up to 25% of familial cases and 18% of sporadic cases. This review examines the complex relationship between TTN variants and DCM, highlighting the challenges posed by incomplete penetrance and variable expressivity. While truncating variants primarily in the A-band region [...] Abstract Titin, encoded by the TTN gene, is the largest human protein, essential for maintaining muscle cell stability and regulating myocardial contraction. TTN truncating variants (TTNtv) have emerged as the most common genetic cause of dilated cardiomyopathy (DCM), accounting for up to 25% of familial cases and 18% of sporadic cases. This review examines the complex relationship between TTN variants and DCM, highlighting the challenges posed by incomplete penetrance and variable expressivity. While truncating variants primarily in the A-band region

5 August 2024 in International Journal of Cardiovascular Sciences
Verified
Journal Article
Open access
PDF file
SFSilas Ramos Furquim
Silas Ramos Furquim
LLLayara Fernanda Vicente Pereira Lipari
Layara Fernanda Vicente Pereira Lipari
FAFernanda Almeida Andrade
Fernanda Almeida Andrade
VCVinícius Machado Correia
Vinícius Machado Correia
NONatalia Quintella Sangiorgi Olivetti
Natalia Quintella Sangiorgi Olivetti
JKJose Krieger
Jose Krieger
Cardiomyopathy is characterized by structural and functional abnormalities in the heart muscle that are not influenced by coronary disease, hypertension, valve disease, or congenital heart defects. Genetic testing, which helps diagnose the molecular bases of cardiomyopathy, can affect prognostication and clinical decisions. Recent guidelines advocate classifying cardiomyopathies based on phenotypic categories, which encompass a range of clinical presentations, underlying causes, and outcomes. Beyond deepening our grasp of the disease, genetic testing can distinguish between diseases with similar presentations, known [...] Abstract Cardiomyopathy is characterized by structural and functional abnormalities in the heart muscle that are not influenced by coronary disease, hypertension, valve disease, or congenital heart defects. Genetic testing, which helps diagnose the molecular bases of cardiomyopathy, can affect prognostication and clinical decisions. Recent guidelines advocate classifying cardiomyopathies based on phenotypic categories, which encompass a range of clinical presentations, underlying causes, and outcomes. Beyond deepening our grasp of the disease, genetic testing can distinguish between diseases with similar presentations, known